Retracted: Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine

Volume: 37, Issue: 6, Pages: 625 - 634
Published: Mar 18, 2016
Abstract
The H2-receptor antagonist, ranitidine, is among the most widely used pharmaceuticals to treat gastroesophageal reflux disease and peptic ulcers. While previous studies have demonstrated that amines can form N-nitrosamines when exposed to nitrite at stomach-relevant pH, N-nitrosamine formation from ranitidine, an amine-based pharmaceutical, has not been demonstrated under these conditions. In this work, we confirmed the production of...
Paper Details
Title
Retracted: Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine
Published Date
Mar 18, 2016
Volume
37
Issue
6
Pages
625 - 634
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.